Bharat Parenterals Limited (BOM:541096)
1,853.70
+31.40 (1.72%)
At close: Nov 6, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 12.78 billion as of November 6, 2026. It is the 22,822nd most valuable company in the world and the 1,474th biggest in India. Its market cap has increased by 51.64% in one year.
Market Cap
12.78B
Enterprise Value
14.00B
Revenue
3.95B
Global Rank
Country Rank
#1,474 India
PE Ratio
1,283.37
ChartMarket Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 12.78B, an increase of 1,297.08%. That is a compound annual growth rate of 35.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 12.78B | 53.27% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 24.06B |
| Syncom Formulations (India) | 17.94B |
| Venus Remedies | 17.63B |
| Amrutanjan Health Care | 14.44B |
| TTK Healthcare | 12.94B |
| Fermenta Biotech | 12.26B |
| Kopran | 11.92B |
| Lincoln Pharmaceuticals | 10.10B |